The Daily Brief

The Daily Brief

A daily podcast that dives into the biggest stories happening in the Indian markets and the global business landscape.
00:00
00:00

Resumen del episodio

In today's episode of The Daily Brief, we cover a deep dive and another story for the day shaping Indian and global markets: 1. The RBI’s 3-Front War on Inflation We’ll cover: Why food prices, crude oil and a weaker rupee are pushing inflation higher. How the RBI’s repo rate hike to 5.50% and currency measures aim to control inflation. How liquidity tightening works and the risks it poses to India’s economic growth. 2. Will Tougher Pharma Rules Change Prescriptions? We’ll cover: What India’s pharmaceutical marketing code (UCPMP) restricts and why its enforcement has faced challenges. How stricter rules could affect pharma companies’ marketing costs, profit margins and sales. Why established drugmakers and trade generics could benefit from changes in how medicines are promoted and sold. Audio Timestamps 00:04 Intro 00:29 How the RBI is fighting inflation 14:43 Who influences your prescription? 24:34 Tidbits We also send out a crisp and short daily newsletter for The Daily Brief. Put your email here and we'll…

Episodios

594-

The RBI’s 3-front war on inflation, explained

In today's episode of The Daily Brief, we cover a deep dive and another story for the day shaping Indian and global markets: 1. The RBI’s 3-Front War on Inflation We’ll cover: Why food prices, crude oil and a weaker rupee are pushing inflation higher. How the RBI’s repo rate hike to 5.50% and currency measures aim to control inflation. How liquidity tightening works and the risks it poses to India’s economic growth. 2. Will Tougher Pharma Rules Change Prescriptions? We’ll cover: What India’s pharmaceutical marketing code (UCPMP) restricts and why its enforcement has faced challenges. How stricter rules could affect pharma companies’ marketing costs, profit margins and sales. Why established drugmakers and trade generics could benefit from changes in how medicines are promoted and sold. Audio Timestamps 00:04 Intro 00:29 How the RBI is fighting inflation 14:43 Who influences your prescription? 24:34 Tidbits We also send out a crisp and short daily newsletter for The Daily Brief. Put your email here and we'll…

15 oct. 2026
593-

The business behind Zetwerk's ₹5,000 crore IPO

In today's episode of The Daily Brief, we cover a deep dive and another story for the day shaping Indian and global markets: 1. Inside Zetwerk’s ₹5,000 Crore IPO We’ll cover: How Zetwerk connects manufacturers, suppliers and industrial customers. Revenue growth, profit margins and the company’s cash flow challenges. How the IPO proceeds will be used to repay debt and fund future growth. 2. Who Pays When It’s Too Hot to Work? We’ll cover: How heatwaves affect workers’ earnings, health and productivity. Why the lack of drinking water, shade and cooling makes the problem worse. How heat action plans, workplace improvements and insurance can help protect workers. Audio Timestamps 00:04 Intro 00:30 Zetwerk’s ₹5,000 crore IPO 14:49 The cost of working in the heat 25:12 Tidbits We also send out a crisp and short daily newsletter for The Daily Brief. Put your email here and we'll make you smart every day: https://thedailybrief.zerodha.com/ Note: This content is for informational purposes only. None of the stocks,…

14 oct. 2026
592-

The US is one step away from banning green cards

In today's episode of The Daily Brief, we cover a deep dive and another story for the day shaping Indian and global markets: 1. The US Is Tightening Green Card Rules We’ll cover: Why the US has frozen PERM applications and how it affects H-1B workers. Why Indian IT companies are reducing their dependence on US work visas. How offshoring, local hiring and AI could reshape the future of Indian IT. 2. India’s Housing Boom Is Narrowing We’ll cover: Why ₹2–5 crore homes are seeing strong demand while affordable housing struggles. How falling affordable housing launches and slower sales are affecting buyers. How rising interest rates and home loan EMIs could impact India’s real estate market. Audio Timestamps 00:04 Intro 00:30 Indian IT vs US immigration rules 13:30 India’s housing market: A growing divide 20:02 Tidbits We also send out a crisp and short daily newsletter for The Daily Brief. Put your email here and we'll make you smart every day: https://thedailybrief.zerodha.com/ Note: This content is for…

13 oct. 2026
591-

Can ₹84,000 crore get India drilling?

In today's episode of The Daily Brief, we cover a deep dive and another story for the day shaping Indian and global markets: 1. Can ₹84,000 Crore Help India Find More Oil? We’ll cover: Why India’s domestic oil production is falling and what untapped reserves could mean. How the Samudra Manthan scheme plans to reduce exploration risks for companies. The challenges of offshore drilling, investment returns and the timeline for new oil production. 2. Why Is Rice Getting Expensive Despite Record Stocks? We’ll cover: How the weak monsoon could affect India’s rice production and food inflation. Why government buffer stocks aren’t effectively bringing down retail rice prices. How ethanol production and lower reservoir levels could affect future rice supplies. Audio Timestamps 00:04 Intro 00:32 Can ₹84,000 crore find India more oil? 13:20 Too much rice, yet higher prices? 20:31 Tidbits We also send out a crisp and short daily newsletter for The Daily Brief. Put your email here and we'll make you smart every day:…

12 oct. 2026
590-

Inside India’s first household travel survey

In today's episode of The Daily Brief, we cover a deep dive and another story for the day shaping Indian and global markets: 1. India’s 25-Minute Commute We’ll cover: Why two-wheelers dominate India’s daily commute while mass transit serves only a small share of workers. What the 25-minute commute really says about Indian cities, jobs and transport costs. How mobility constraints affect women, students and rural households. 2. Why Are Cancer Drugs Marked Up 10x? We’ll cover: How India regulates the prices of scheduled and non-scheduled medicines. Why a high initial MRP can still leave room for large margins .How the government’s proposed 30% trade-margin cap could affect non-scheduled anti-cancer medicines. Audio Timestamps 00:04 Intro 01:04 Inside India’s travel survey 14:20 Can cancer drugs get cheaper? 22:29 Tidbits We also send out a crisp and short daily newsletter for The Daily Brief. Put your email here and we'll make you smart every day: https://thedailybrief.zerodha.com/ Note: This content is for…

Fri, 9 Oct 2026 02:24:55 +0000